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An electrospray mass spectrometric approach to the identification of a human hemoglobin
(Hb) variant involving a Cys residue incorporation is presented. In Hb Ta-Li (83Gly3 Cys),
Cys83 forms inter-molecular disulfide bridges. Routine analysis of the denatured Hb showed
the presence of a minor  chain variant whose mass apparently was 1 Da less than the expected
mass difference of 46 Da for a Gly 3 Cys substitution. Reduction of the globin chains with
dithiothreitol gave an intense monomer with the expected mass difference for the Gly3 Cys
substitution. After reprocessing the original raw data from the denatured Hb and taking into
account the possibility of dimer formation, a component was revealed whose mass was
consistent with a disulfide linked dimer of Ta-Li  globins. The mutation was localized to
peptide T10 by analysis of a tryptic digest. Tandem mass spectrometry and DNA sequencing
confirmed the Gly 3 Cys substitution occurred at residue 83 of the  chain. Problems
encountered in identifying the components in mixtures of monomers and dimers are
discussed. (J Am Soc Mass Spectrom 2002, 13, 187–191) © 2002 American Society for Mass
Spectrometry
Mass spectrometry has become widely used inthe investigation of Hb variants since it wasfirst used by Wada et al. as a novel method for
the identification of variant Hb in 1981 [1–10]. Electro-
spray (ES) in combination with tandem mass spectro-
metry (MS/MS) is a commonly used technique for the
identification of Hb variants [2–10]. Shackleton and
Witkowska [3] and more recently Wild et al. [4] have
elaborated the application of ES mass spectrometry to
the identification of Hb variants. In our laboratory ES
mass spectrometry is used as a secondary as well as a
final tool in the identification process following screen-
ing of the blood samples by HPLC and/or isoelectric
focusing [5, 6]. Initially, denatured blood samples are
analyzed by ES mass spectrometry in order to deter-
mine accurately the molecular masses of the proteins
present. Software based on maximum entropy (Max-
Ent) is generally used to process the raw data [7]. This
software automatically deconvolutes the original mul-
tiply charged data, and allows the mass of the aberrant
globin chain in a heterozygote to be determined to a
fraction of a Dalton, provided that its mass differs by
more than 6 Da from the normal chain [3]. In routine
work, the deconvolution parameters are usually chosen
on the assumption that only monomeric globin chains
are likely to be present in order to minimize the
processing time (30 s). ES mass spectrometry has been
used not only to identify Hb variants but also to
characterize post-translational modifications of mutant
amino acids in some Hb variants [8–10].
Only 13 cases out of over 800 Hb variants described
to date involve an amino acid replacement by a cystei-
nyl residue [11]. Besides being an uncommon substitu-
tion, a possible explanation for the low number of Cys
containing Hb variants could be that almost all of the
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possible single base substitutions generate neutral to
neutral amino acid exchange (Gly 3 Cys, Phe 3 Cys,
Ser3 Cys, Trp3 Cys, Tyr3 Cys) which tend to escape
detection by charge based separation techniques. In
several cases the newly occurring Cys residue forms an
inter-molecular or intra-molecular disulfide (–S–S–)
bridge. In Hb Poˆrto Alegre (9Ser 3 Cys), the first
described variant involving Cys, the Cys residue is
present on the external surface of the Hb tetramer and
therefore forms inter-molecular –S–S– bridges [12]. Hb
Rainier (145Tyr 3 Cys), the most extensively studied
Cys containing variant, involves the internal 12 con-
tact of the Hb molecule and forms intra-molecular
–S–S– bridges with 93Cys [13]. On the other hand, in
Hb Nunobiki (141Arg 3 Cys) where the variant
substitution is at the C-terminal end (internal 12
contact), no intra- or inter-molecular –S–S– bridges
were observed [14].
The variant reported here is also a Cys containing
variant known to polymerize in vitro via –S–S– bonds
between the variant  chains. This communication
describes the mass spectrometric approach to the char-
acterization of this enigmatic and rare Hb variant. A
drawback of employing the deconvolution technique is
discussed.
Experimental
Isoelectric Focusing and HPLC
Abnormal Hb fractions were found during routine
diabetic screening (i.e., quantification of glycated Hbs)
by ion exchange HPLC of blood samples from two
subjects of Swedish origin living in the same geograph-
ical region. Isoelectric focusing and anion exchange
HPLC were performed as previously described [15].
Mass Spectrometry
All ES experiments were performed on a Quattro Ul-
tima triple quadrupole mass spectrometer (Micromass,
Altrincham, UK). A stock solution of 50-fold diluted
whole blood was prepared in water. A mass spectro-
metric sample was made by 10-fold dilution of the stock
solution with solvent A (1:1 acetonitrile:water contain-
ing 0.2% formic acid) and desalted as previously de-
scribed [4]. The sample was introduced into the ES ion
source at a flow rate of 8 L/min. The needle-to-
skimmer (capillary voltage) potential was 3.0 kV. The
declustering potential (cone voltage) was set to 75 V.
Data were acquired over an m/z range 930–1180 and
accumulated for 2 min. The raw data were calibrated
internally against the normal  chain and deconvoluted
onto a true mass scale using the MaxEnt based program
supplied with the mass spectrometer. Proportions of the
variants were estimated as described previously [5].
For the tryptic digests, data were acquired by scan-
ning from m/z 150 to 2100 at 8 s per scan for 3 min. The
cone ramp gradient was set from 15 V at m/z 150 to 200
V at m/z 2000. The m/z scale was internally calibrated
from normal  and  chain tryptic peptides present in
the digests.
Dithiothreitol (DTT) Reduction and
S-Carboxyamidomethylation
Reduction was effected by adding 10 L of 100 mM
DTT and 120 L of acetonitrile to 120 L of Hb stock
solution. S-Carboxyamidomethylation of Cys residues
in globin chains was performed by mixing all of the
DTT reduced Hb solution with 10 L of 1 M aqueous
ammonium bicarbonate pH 8.0 and 12 L of 200 mM
aqueous iodoacetamide solution. The mixture was in-
cubated for 15 min at room temperature. A working
sample solution was prepared by mixing 20 L of the
reduced sample with 180 L of solvent A and analyzed
on the mass spectrometer to confirm the appropriate
derivatization. The remainder of the derivatized Hb
sample was subjected to tryptic digestions after remov-
ing the excess reagents using a 10 kDa cut off centrifuge
filter (Microcon YM-10, Millipore Corporation, Bedford
MA).
Tryptic Digestion
Trypsinization (Sigma T-8642) was performed on both
carboxyamidomethylated (CAM) and on denatured Hb
stock solutions in 50 mM ammonium bicarbonate buffer
solution at pH 8.0 [4]. After 30 min at 37 °C, a 20 L
aliquot of the digest was withdrawn and diluted 10-fold
with solvent A. The remainder was left to digest for
12 h. An aliquot of the 12 h digest solution was reduced
with 10 mM DTT followed by dilution with solvent A
for mass analysis of peptides and subsequent MS/MS
experiments.
Tandem Mass Spectrometry
The precursor ion for the peptide of interest was se-
lected and subjected to collision induced dissociation
with methane as the collision gas. The cone voltage was
set at 80 V. The “collision energy” was set at 50 V. The
product ions were analyzed on the final quadrupole of
the instrument. Data were acquired over the m/z range
50–2000 for 10 min. The m/z scale was calibrated against
the Nan1In ions from a separate introduction of sodium
iodide (1 mg/mL in 1:1 2-propanol:water).
Results and Discussion
Isoelectric Focusing and HPLC
Routine quantification of glycated Hb by ion exchange
HPLC of the fresh (less than two weeks old) blood
samples revealed the presence of an abnormal Hb. The
electrophoretic study showed that the abnormal Hb had
a lower isoelectric point than normal Hb with mobility
comparable to Hb Fukuyama (77His 3 Tyr). This
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suggested that a negative charge is gained in the amino
acid exchange event, i.e., neutral to acidic amino acid or
basic to neutral amino acid exchange. The proportions
of the variants determined by anion exchange HPLC
were 32 and 39% of the total Hb. Both subjects showed
no hematological or clinical manifestations. A structural
study of the Hb variant was performed by ES mass
spectrometry of blood samples from both subjects and
data from one of them are presented below.
Mass Spectrometry
The initial ES mass spectrum of the denatured intact
globins following routine MaxEnt processing showed a
normal  chain (15,126.4 Da), and a variant  chain
apparently 45 Da heavier than the mass of the normal 
chain (15,867.2 Da) (Figure 1b). The proportions of the
variant ranged from 26% to well below 15% of the total
 chains, and were low compared to those observed by
HPLC (32% of total Hb) and decreased as the samples
aged. Since there are not any single amino acid substi-
tutions that result in a 45 Da change, a mass measure-
ment error (1 Da) was considered. There are two
possible amino acid substitutions that will yield a 44
Da mass shift, i.e., Ala3 Asp and Cys3 Phe and only
one (Gly 3 Cys) for a 46 Da change. Because the
Cys 3 Phe and Gly 3 Cys substitutions are neutral to
neutral amino substitutions and do not agree with the
isoelectric focusing pattern, these substitutions were
considered unlikely. Believing Ala 3 Asp to be the
most likely substitution, we set about analyzing the
tryptic fragments. However, prior to digestion, reduc-
tion followed by CAM derivatisation of the Cys resi-
dues was performed. Normal Hb from an adult carries
one Cys in each  chain and two Cys residues in each 
chain. Analysis of the reaction products by ES mass
spectrometry showed the presence of an extra Cys
residue in the  chain indicating that the variant in-
volves an amino acid replacement by a Cys residue
(Figure 1c). The observed mass difference between the
variant and the derivatized normal  chain was equiv-
alent to 1 CAM 46 Da. There is only one possible
amino acid substitution that gives 46 Da change, i.e.,
Gly 3 Cys. Subsequent analysis of the DTT-reduced
intact globin chains also displayed the 46 Da increase
(Figure 1d). The proportion of the variant was 37% of
total  chains as judged from the CAM intact chains.
Mass spectra of a 30 min tryptic digest displayed
(data not shown) an abnormal T10–T11 fragment
suggesting that the variant lies in this fragment. The
presence of this fragment after the short digestion time
shows the inefficiency of trypsin to cleave at its target
residue (95Lys) when occurring C-terminal to an
acidic residue (94Asp). On analysis of the 12 h digests,
peptides reduced with DTT showed peaks at the ex-
pected m/z of the variant T10 peptide (Figure 2). The
intensity of the normal T102 peptide ion (m/z 711.4) in
the variant sample (Figure 2b) was lower than in the
control sample (Figure 2a), while a peak at m/z 734.4, 23
Th heavier than the normal T102 peptide appeared.
This implies the mutation is 83 (Gly3 Cys) since there
is only one Gly residue in the normal tryptic T10
peptide (GTFATLSELHCDK), corresponding to residue
83 in the normal  chain. Subsequent MS/MS analysis
of the doubly protonated variant and normal peptides
showed the same m/z values for members of the com-
plete y ion series, while m/z values for b2–b4 ions and
beyond were increased by 46 Th (Figures 3a and b).
These observations corroborate the mutation 83 (Gly
3 Cys). When Gly at this position is replaced by Cys a
46 Da change occurs. This has previously been re-
ported in a Chinese family as Hb Ta-Li (83Gly3 Cys)
[16]. Although Gly3 Cys is a neutral to neutral amino
acid substitution, the isoelectric focusing results indi-
cated it to be an anodal variant (gain in negative charge)
from normal Hb. This may be due to the oxidation of
thiol group of reactive Cys to form cysteine-sulfinic acid
Figure 1. Deconvoluted ES mass spectra from (a) denatured
normal blood, (b) denatured blood of a heterozygote carrying Hb
Ta-Li, (c) blood of a heterozygote carrying Hb Ta-Li after DTT
reduction and carboxyamidomethylation (CAM), and (d) blood of
a heterozygote carrying Hb Ta-Li after DTT reduction. CAM adds
57.05 Da per free Cys.
Figure 2. Part of ES mass spectra of tryptic digests from (a) a
diluted normal blood sample and (b) a mixture of Hbs from a
heterozygous carrier of Hb Ta-Li showing the 23 Th shift in
T102 peptide ion.
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(Cys-SO2H) or cysteine-sulfonic acid (Cys-SO3H), how-
ever there was no conclusive evidence for this in the
mass spectra of the sample analyzed.
An earlier study has also shown that the variant
polymerizes in vitro through inter-molecular –S–S–
bridges [16]. Decreasing proportions of the variant in
the unmodified blood sample in consecutive runs over
a period of 120 days indicated rapid in vitro polymer-
ization. Dimers were evident in the present study on 20
weeks old sample as shown by a series of multiply
charged ions (D) in the raw data obtained from the
denatured blood sample (Figure 4a). The D ions with
odd numbers of charges can only arise from the dimer,
and together with the D ions with even numbers of
charges, form a fairly regular multiply charged series.
In other words, the evenly charged D ions do not
appear to be significantly more intense than the oddly
charged D ions, implying the variant is mainly present
as the dimer. Note that the evenly charged D ions could
also arise from the monomer, since these species differ
in m/z by only 1 part in 15,913, well beyond the
resolving capabilities of the technique (6 Da in 16,000
Da [3]). After the sample was reduced with DTT (Figure
4b), the D ions with odd numbers of charges disap-
peared concomitantly with a marked increase in the
intensity of ions very close in m/z to the D ions with
even numbers of charges, implying conversion of dimer
to monomer. After reprocessing the raw data used to
generate Figure 1a by MaxEnt so as to accommodate the
possible presence of dimers (output mass range of
14,800–33,500 Da), the Ta-Li dimer was observed (Fig-
ure 5),with essentially no monomer (Figure 5 inset).
Note that the MaxEnt deconvoluted spectrum exhibits
negligible levels of artifactual dimers from the intense
normal - and -chains, and also shows a component of
mass 28,781.3 Da, attributable to carbonic anhydrase I
(N-acetylated sequence mass 28,781.1 Da), adding cred-
ibility to faithful deconvolution of the original data. In
the strictest sense, the output mass range parameter in
the MaxEnt software should encompass all the compo-
nents in the m/z spectrum. Otherwise the program will
generate artifacts. In routine analysis of denatured Hbs,
we generally assume that only monomeric chains are
present in order to limit the processing time to 30 s,
which increases to7 min when dimers are assumed to
be present. When only monomers are assumed to be
present in a spectrum containing dimers, minor artifacts
produced by components such as carbonic anhydrase
can generally be ignored, but the software generates an
artefactual monomer. The apparent monomeric variant
 chain at 15,912.2 Da (Figure 1b) is an artifact caused
by operating the deconvolution software with a limited
output mass range (14,800–16,800 Da) and appears at
half the mass of the dimer (31,824.6/2 Da). The mass
difference of 1 Da per chain from the expected mass
change is explained by inter-molecular –S–S– bond
Figure 3. Tandem mass spectra of (a) normal T102 peptide ion
and (b) variant T102 peptide ion. Shown in the inset is the
amino acid sequence of the T10 peptide.
Figure 4. Part of ES mass spectra from (a) unmodified blood of a
heterozygote carrying Hb Ta-Li showing the presence of peaks
corresponding to the dimer; (b) DTT reduced mixture of Hbs from
a heterozygous carrier of Hb Ta-Li. The mass spectra show the
multiply charged ions of normal  (A), normal  (B), monomeric
Ta-Li (C), and dimeric Ta-Li (D) globins. The data from (a) were
deconvoluted to generate the spectra in Figure 1(b) and Figure 5,
while the data from (b) were used to generate Figure 1(d).
Figure 5. Deconvoluted ES mass spectrum from a mixture of
Hbs from a heterozygous carrier of Hb Ta-Li showing the dimeric
nature of Ta-Li globins. Also encompassed in this figure is the
mass of N-acetylated carbonic anhydrase I (28,781.3 Da). The inset
shows essentially no monomeric Ta-Li  globins.
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formation where each variant  subunit loses one
hydrogen atom from the newly introduced Cys residue.
If there had been an intra-molecular –S–S– bridge, the
expected mass difference per chain would be 2 Da,
which has been observed by others in the monomer Hb
Rainier [13]. This Ta-Li example illustrates how limiting
the deconvolution output mass range can give mislead-
ing results when there are dimers in the sample, a
situation that can be remedied by reprocessing the data
to accommodate dimers or by reducing the sample.
Nevertheless, distinguishing the components in mono-
mer–dimer mixtures by mass spectrometry remains
problematical, particularly when present at relatively
low levels as in this case, and recourse to the original
data should be made along the lines of Figure 4 in order
to increase confidence in the interpretation.
This is the first case of Hb Ta-Li (83Gly 3 Cys)
reported in a Caucasian patient. DNA sequencing re-
vealed a G 3 T base substitution in the codon corre-
sponding to Gly (GGC) 3 Cys (TGC).
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